低剂量化疗联合酪氨酸激酶抑制剂诱导治疗Ph染色体阳性急性淋巴细胞白血病的疗效和安全性

OBJECTIVE: The study aims to explore the efficacy and safety of low-dose chemotherapy combined with tyrosine kinase inhibitor (TKI) as an induction therapy for Philadelphia-chromosomal-positive acute lymphoblastic leukemia (Ph(+) ALL). METHODS: The data of the consecutive newly diagnosed patients wi...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395566/
https://www.ncbi.nlm.nih.gov/pubmed/36709131
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.07.004

Ejemplares similares

Ejemplares similares